Document is current
Any future updates will be listed below
-
Authors
Wang, Baoxin https://orcid.org/0000-0003-3230-2743
Wu, Zhenming https://orcid.org/0000-0003-4685-2789
Zhang, Rui https://orcid.org/0000-0002-7574-7390
Chen, Yue https://orcid.org/0000-0001-7328-4081
Dong, Jiuxing https://orcid.org/0000-0002-6765-7061
Qi, Xiuheng https://orcid.org/0000-0003-2645-2796
-
Funding
Funding for this research was provided by:
Langfang Science and Technology Support Project of Hebei Province (2020013089)
- License Information
-
More Information
Article History
Received: 17 January 2021
Accepted: 18 March 2021
First Online: 6 April 2021
Declarations
:
: None.
: The designed protocol (2020013089 dated 22 July 2020) was approved by the Hebei Petrochina Central Hospital's review board and the Society of Chinese surgeons. The study reporting adheres to the law of China and the v2008 Declarations of Helsinki. An informed consent form was signed by relatives (legally authorized person) of patients regarding diagnosis, surgery, pathology (if any), chemotherapy, and publication of the anonymized information of patients in the form of the article during hospitalization. As the study was a retrospective analysis, the registration in the Chinese Clinical Trial Registry was waived by the institutional review board.
: The authors declare that they have no competing interests.
